Abbott Laboratories planned insider sales
In the last twelve months insiders at Abbott Laboratories filed 13 Form 144 notices of planned sales, 450,792 shares worth $51.3 million at the time of filing, from 8 sellers. The latest, filed 5 November 2026: Mary K. Moreland (officer), 3,500 shares worth $406,000, planned for around 5 November 2026 through UBS Financial Services, Inc..
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 5 November 2026 | Mary K. Moreland | Officer | 3,500 | $406,000 | 5 November 2026 | 3,500 shares from 5 November 2026 | UBS Financial Services, Inc. | Restricted Stock Award Vested | Form 144 |
| 2 September 2026 | John A. McCoy, Jr. | Officer | 27 | $2,957 | 2 September 2026 | 27 shares from 2 September 2026 | UBS Financial Services, Inc. | Restricted Stock Award Vested | Form 144 |
| 25 August 2026 | Robert B. Ford | Officer, Director | 398,832 | $46.2 million | 25 August 2026 | 398,832 shares from 25 August 2026 | UBS Financial Services, Inc. | Exercise of Stock Options | Form 144 |
| 11 August 2026 | Louis H. Morrone | Officer | 5,850 | $642,506 | 11 August 2026 | 5,850 shares from 11 August 2026 | UBS Financial Services, Inc. | Restricted Stock Award Vested | Form 144 |
| 15 May 2026 | Robert J. Alpern | Retired Director | 7,587 | $646,791 | 15 May 2026 | No matching Form 4 sale | Janney Montgomery Scott LLC | RSUs Paid In Shares | Form 144 |
| 27 April 2026 | Robert J. Alpern | Retired Director | 29,211 | $2.7 million | 27 April 2026 | No matching Form 4 sale | UBS Financial Services, Inc. | Restricted Stock Units | Form 144 |
| 2 March 2026 | Elizabeth C. Cushman | Officer | 263 | $30,397 | 2 March 2026 | 263 shares from 2 March 2026 | UBS Financial Services, Inc. | Restricted Stock Award Vested | Form 144 |
| 2 March 2026 | John A. McCoy, Jr. | Officer | 585 | $67,614 | 2 March 2026 | 585 shares from 2 March 2026 | UBS Financial Services, Inc. | Restricted Stock Award Vested | Form 144 |
| 2 March 2026 | Mary K. Moreland | Officer | 613 | $70,850 | 2 March 2026 | 613 shares from 2 March 2026 | UBS Financial Services, Inc. | Restricted Stock Award Vested | Form 144 |
| 2 March 2026 | Eric Shroff | Officer | 709 | $81,946 | 2 March 2026 | 709 shares from 2 March 2026 | UBS Financial Services, Inc. | Restricted Stock Award Vested | Form 144 |
| 2 March 2026 | Daniel Gesua Sive Salvadori | Officer | 885 | $102,288 | 2 March 2026 | 885 shares from 2 March 2026 | UBS Financial Services, Inc. | Restricted Stock Award Vested | Form 144 |
| 2 March 2026 | Louis H. Morrone | Officer | 1,144 | $132,223 | 2 March 2026 | 1,144 shares from 2 March 2026 | UBS Financial Services, Inc. | Restricted Stock Award Vested | Form 144 |
| 25 November 2025 | Eric Shroff | Officer | 1,586 | $203,042 | 25 November 2025 | 1,586 shares from 25 November 2025 | UBS Financial Services, Inc. | Restricted Stock Award Vested | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.